# Cytomegalovirus host receptor expression in the human fetal inner ear

**Authors:** Lucia C. M. Grijpink, Wouter H. van der Valk, Edward S. A. van Beelen, John C. M. J. de Groot, Heiko Locher, Ann C. T. M. Vossen

PMC · DOI: 10.1371/journal.pone.0320605 · 2025-03-31

## TL;DR

This study identifies cell types in the human fetal inner ear that express receptors for cytomegalovirus, which may explain how the virus causes hearing and balance issues in fetuses.

## Contribution

The study is the first to map the expression of hCMV host receptors in the fetal inner ear across developmental stages.

## Key findings

- PDGFRA is expressed in mesenchymal cells of the fetal inner ear.
- NRP2 is expressed in epithelial and endothelial cells.
- EGFR is expressed in both epithelial and mesenchymal cells during the first and second trimesters.

## Abstract

Fetal infection with human cytomegalovirus (hCMV) can cause sensorineural hearing loss and vestibular impairment, yet its pathogenesis remains unclear. This study aims to identify potential target cell types of hCMV in the human fetal inner ear. Viral particles use several envelope glycoproteins to enter target cells, including the pentameric complex, the trimeric complex and glycoprotein B. Platelet-derived growth factor receptor alpha (PDGFRA) serves as the receptor in fibroblasts, neuropilin-2 (NRP2) in epithelial, endothelial and dendritic cells as well as in leukocytes. Upon binding of these glycoproteins, glycoprotein B initiates membrane fusion which is proposed to be mediated by EGFR. When and where these proteins are expressed in the fetal inner ear during development is unknown. To address this, expression patterns of PDGFRA, NRP2 and EGFR were investigated in human fetal inner ear tissue using single-nucleus RNA sequencing data (first trimester: N = 2) and immunohistochemistry (first trimester: N = 6, second trimester: N = 5). PDGFRA gene and protein expression was detected in mesenchymal cells, NRP2 protein expression in epithelial cells and endothelial cells, and EGFR gene and protein expression in both epithelial cells and mesenchymal cells. Notably, all three receptors were present in tissue from the first and second trimesters. In conclusion, hCMV host receptors PDGFRA, NRP2 and EGFR are expressed in mesenchymal, epithelial and endothelial cells within the cochlea and vestibular organs during the first and second trimesters. These cell types may serve as targets for hCMV infection of the fetal inner ear.

## Linked entities

- **Genes:** PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156], NRP2 (neuropilin 2) [NCBI Gene 8828], EGFR (epidermal growth factor receptor) [NCBI Gene 1956]
- **Proteins:** PDGFRA (platelet derived growth factor receptor alpha), NRP2 (neuropilin 2), EGFR (epidermal growth factor receptor)
- **Diseases:** sensorineural hearing loss (MONDO:0010576)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** NRP2 (neuropilin 2) [NCBI Gene 8828] {aka NP2, NPN2, PRO2714, VEGF165R2}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** sensorineural hearing loss (MESH:D006319), Fetal infection with (MESH:D005315), infection (MESH:D007239), vestibular impairment (MESH:D015837)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human betaherpesvirus 5 (no rank) [taxon 10359]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11957294/full.md

---
Source: https://tomesphere.com/paper/PMC11957294